01 6Betaferon/Betaseron
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 489
2019 Revenue in Millions : 553
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 371
2020 Revenue in Millions : 489
Growth (%) : -17
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 327
2021 Revenue in Millions : 371
Growth (%) : -12
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 252
2022 Revenue in Millions : 327
Growth (%) : -25
Main Therapeutic Indication : Neurological/Mental Disorders
Currency : USD
2018 Revenue in Millions : 615
2017 Revenue in Millions : 736
Growth (%) : -16%
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 498
2018 Revenue in Millions : 593
Growth (%) : -16
